Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

NCT03436654 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Apalutamide
DRUG: Abiraterone Acetate
DRUG: Prednisone
DRUG: GnRH agonist/antagonist

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]